Many semaglutide users deviate from recommended dose‐escalation schedules and discontinue treatment, highlighting the need ...

As a mass rollout of weight loss injections begins across the NHS, with GPs able to prescribe Mounjaro for the first time ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

MHRA says users of jabs such as Wegovy and Mounjaro reported inflamed pancreas - which can cause agonising abdominal pain - ...

Whitney Way Thore has been open about her confidence journey since premiering 'My Big Fat Fabulous Life' in 2015, including ...

After one month, the average weight loss on Rybelsus is around 2 kg; after two months, it’s over 3 kg. THE SIDE EFFECTS OF A PILL “I constantly had nausea, vomitting, diarrhoea, fatigue, constipation ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Trend alert! Split dosing, stretch dosing, skip dosing, microdosing Ozempic… People are finding creative ways to use ...

Both semaglutide and tirzepatide belong to a new class of medicines called GLP-1 (glucagon-like peptide-1) receptor agonists. They are prescribed for the management of type-2 diabetes and obesity.

This viral TikTok trend is also known as "fibermaxxing," and it's an easy way to boost satiety and help melt stubborn pounds.

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.